Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach

NCT03540654 · clinicaltrials.gov ↗
COMPLETED
Status
355
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Bordeaux

Collaborators